Cryosurgical ablation of renal cell carcinoma

Cancer Control

Volumn 14, Issue 3, 2007, Pages 211-217

  Hafron, Jason ^a   Kaouk, Jihad H ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABSCESS; ANEMIA; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER PATIENT; CANCER STAGING; CANCER SURVIVAL; CANCER THERAPY; CRYOABLATION; CRYOBIOLOGY; ESOPHAGITIS; FEVER; FOLLOW UP; FRACTURE; HEART FAILURE; HEMATURIA; HUMAN; IMAGING; KIDNEY CARCINOMA; KIDNEY HEMORRHAGE; KIDNEY INJURY; KIDNEY TUMOR; LAPAROSCOPIC SURGERY; LITERATURE; LUNG EDEMA; MORBIDITY; OVERALL SURVIVAL; PARTIAL NEPHRECTOMY; PERIRENAL ABSCESS; PLEURA EFFUSION; POSTOPERATIVE HEMORRHAGE; RETROPERITONEAL HEMORRHAGE; RETROSPECTIVE STUDY; REVIEW; SPLEEN HEMATOMA; TISSUE INTERACTION; TUMOR VOLUME; URETEROPELVIC JUNCTION OBSTRUCTION; VALIDATION STUDY;

EID: 34447312507     PISSN: 10732748     EISSN: 15262359     Source Type: Journal    
DOI: 10.1177/107327480701400303     Document Type: Review

References (55)

1. Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2007. CA Cancer J Clin. 2007;57:43-66.
2. Parkin DM, Whelan SL, Ferlay J, et al, eds. IARC Scientific Publication No. 155. Cancer Incidence in Five Continents. Vol. VIII. Lyon, France: International Agency for Research on Cancer; 2002.
3. Fergany AF, Hafez KS, Novick AC. Long-term results of nephron sparing surgery for localized renal cell carcinoma: 10-year followup. J Urol. 2000;163:442-445.
4. Lee CT, Katz J, Shi W, et al. Surgical management of renal tumors 4 cm or less in a contemporary cohort. J Urol. 2000;163:730-736.
5. Chow WH, Devesa SS, Warren JL, et al. Rising incidence of renal cell cancer in the United States. JAMA. 1999;281:1628-1631.
6. Lightfoot N, Conlon M, Kreiger N, et al. Impact of noninvasive imaging on increased incidental detection of renal cell carcinoma. Eur Urol. 2000;37:521-527.
7. Luciani LG, Cestari R, Tallarigo C. Incidental renal cell carcinoma-age and stage characterization and clinical implications: study of 1092 patients (1982-1997). Urology. 2000;56:58-62.
8. Bretheau D, Lechevallier E, Eghazarian C, et al. Prognostic significance of incidental renal cell carcinoma. Eur Urol. 1995:27:319-323.
9. Jayson M, Sanders H. Increased incidence of serendipitously discovered renal cell carcinoma. Urology. 1998;51:203-205.
10. Homma Y, Kawabe K, Kitamura T, et al. Increased incidental detection and reduced mortality in renal cancer: recent retrospective analysis at eight institutions. Int J Urol. 1995;2:77-80.
11. Nguyen MM, Gill IS, Ellison LM. The evolving presentation of renal carcinoma in the United States: trends from the Surveillance, Epidemiology and End Results program. J Urol. 2006;176(6 pt 1):2397-2400.
12. Hollenbeck BK, Taub DA, Miller DC, et al. National utilization trends of partial nephrectomy for renal cell carcinoma: a case of underutilization? Urology. 2006;67:254-259. Epub 2006 Jan 25.
13. Bosniak MA. The small (less than or equal to 3.0 cm) renal parenchymal tumor: detection, diagnosis, and controversies. Radiology. 1991;179:307-317.
14. Bosniak MA, Birnbaum BA, Krinsky GA, et al. Small renal parenchymal neoplasms: further observations on growth. Radiology. 1995;197:589-597.
15. Snyder ME, Bach A, Kattan MW, et al. Incidence of benign lesions for clinically localized renal masses smaller than 7 cm in radiological diameter: influence of sex. J Urol. 2006;176(6 pt 1):2391-2395.
16. Campbell SC, Novick AC, Herts B, et al. Prospective evaluation of fine needle aspiration of small, solid renal masses: accuracy and morbidity. Urology. 1997;50:25-29.
17. Wehle MJ, Thiel DD, Petrou SP, et al. Conservative management of incidental contrast-enhancing renal masses as safe alternative to invasive therapy. Urology. 2004;64:49-52.
18. McKiernan J, Simmons R, Katz J, et al. Natural history of chronic renal insufficiency after partial and radical nephrectomy. Urology. 2002;59:816-820.
19. Lau WK, Blute ML, Weaver AL, et al. Matched comparison of radical nephrectomy vs nephron-sparing surgery in patients with unilateral renal cell carcinoma and a normal contralateral kidney. Mayo Clin Proc. 2000;75:1236-1242.
20. Clark PE, Schover LR, Uzzo RG, et al. Quality of life and psychological adaptation after surgical treatment for localized renal cell carcinoma: impact of the amount of remaining renal tissue. Urology. 2001;57:252-256.
21. Huang WC, Levey AS, Serio AM, et al. C hronic kidney disease after nephrectomy in patients with renal cortical tumours: a retrospective cohort study. Lancet Oncol. 2006;7:735-740.
22. Lutzeyer W. Advancements in operative therapy (urology). Langenbecks Arch Chir. 1972;332:137-145.
23. Lutzeyer W, Lymberopoulos S, Breining H, et al. Experimental cryosurgery of the kidney. Langenbecks Arch Chir. 1968;322:843-847.
24. Chosy SG, Nakada SY, Lee FT Jr, et al. Monitoring renal cryosurgery: predictors of tissue necrosis in swine. J Urol. 1998;159:1370-1374.
25. Woolley ML, Schulsinger DA, Durand DB, et al. Effect of freezing parameters (freeze cycle and thaw process) on tissue destruction following renal cryoablation. J Endourol. 2002;16:519-522.
26. Campbell SC, Krishnamurthi V, Chow G, et al. Renal cryosurgery: experimental evaluation of treatment parameters. Urology. 1998;52:29-34.
27. Mazur P. Freezing of living cells: mechanisms and implications. Am J Physiol. 1984;247(3 pt 1):C125-C142.
28. Hoffmann NE. Bischof JC. The cryobiology of cryosurgical injury. Urology. 2002;60:40-49.
29. Daum PS, Bowers WD Jr, Tejada J, et al. Vascular casts demonstrate microcirculatory insufficiency in acute frostbite. Cryobiology. 1987;24:65-73.
30. Hoffmann NE and Bischof JC. Cryosurgery of normal and tumor tissue in the dorsal skin flap chamber. Part II: injury response. J Biomech Eng. 2001;123:310-316.
31. Baust JG, Gage AA, Clarke D, et al. Cryosurgery: a putative approach to molecular-based optimization. Cryobiology. 2004;48:190-204.
32. Davol PE, Fulmer BR, Rukstalis DB. Long-term results of cryoablation for renal cancer and complex renal masses. Urology. 2006;68(1 suppl):S2-6.
33. Cestari A, Guazzoni G, Naspro R, et al. Laparoscopic renal cryoablation (LRC) of small renal masses: lesson learned after 70 procedures. Eur Urol Suppl. 2006;5:220.
34. Gill IS, Remer EM, Hasan WA, et al. Renal cryoablation outcome at 3 years. J Urol. 2005;173:1903-1907.
35. Hegarty NJ, Gill IS, Spaliviero M, et al. Renal cryoablation: 5 year outcomes. J Urol. 2006;175(suppl):351. Abstract 1091.
36. Gupta A, Allaf ME, Kavoussi LR, et al. Computerized tomography guided percutaneous renal cryoablation with the patient under conscious sedation: initial clinical experience. J Urol. 2006;175:447-453.
37. Silverman SG, Tuncali K, vanSonnenberg E, et al. Renal tumors: MR imaging-guided percutaneous cryotherapy: intial experience in 23 patients. Radiology. 2005;236:716-724.
38. Sewell P, Shingleton W. Five-year treatment success and survival of patients treated with percutaneous IMRI guided and monitored renal cell carcinoma cryoablation. BJU Int. 2004;94:106. Abstract MP-1609.
39. Johnson DB, Solomon SB, Su LM, et al. Defining the complications of cryoablation and radio frequency ablation of small renal tumors: a multi-institutional review. J Urol. 2004;172:874-877.
40. Carvalhal EF, Gill IS, Meraney AM, et al. Laparoscopic renal cryoablation: impact on renal function and blood pressure. Urology. 2001;58:357-361.
41. Sung GT, Gill IS, Hsu TH, et al. Effect of intentional cryo-injury to the renal collecting system. J Urol. 2003;170:619-622.
42. Warlick CA, Lima GC, Allaf ME, et al. Clinical sequalae of radiographic ice ball involvement of collecting system during computed tomography-guided percutaneous renal tumor cryoablation. Urology. 2006;67:918-922.
43. Remer EM, Weinberg EJ, Oto A, et al. MR imaging of the kidneys after laparoscopic cryoablation. AJR Am J Roentgenol. 2000;174:635-640.
44. Anderson JK, Shingleton WB, Cadeddu JA. Imaging associated with percutaneous and intraoperative management of renal tumors. Urol Clin North Am. 2006;33:339-352.
45. Gervais DA, McGovern FJ, Arellano RS, et al. Radiofrequency ablation of renal cell carcinoma: Part 1. Indications, results, and role in patient management over a 6-year period and ablation of 100 tumors. AJR Am J Roentgenol. 2005;185:64-71.
46. Varkarakis IM, Allaf ME, Inagaki T, et al. Percutaneous radio frequency ablation of renal masses: results at a 2-year mean followup. J Urol. 2005;174:456-460.
47. Deane LA, Clayman RV. Review of minimally invasive renal therapies: needle-based and extracorporeal. Urology. 2006;68(1 suppl):26-37.
48. Ponsky LE, Crownover RL, Rosen MJ, et al. Initial evaluation of cyberknife technology for extracorporeal renal tissue ablation. Urology. 2003;61:498-501.
49. Ankem MK, Nakada SY. Needle-ablative nephron-sparing surgery. BJU Int. 2005;95(2 suppl):46-51.
50. de Jode MG, Vale JA, Gedroyc WM. MR-guided laser thermoablation of inoperable renal tumors in an open-configuration interventional MR scanner: preliminary clinical experience in 3 cases. J Magn Reson Imaging. 1999;10:545-549.
51. Wacker FK, Vogt S, Khamene A, et al. An augmented reality system for MR image-guided needle biopsy: initial results in a swine model. Radiology. 2006;238:497-504.
52. Solomon SB, Patriciu A, Bohlman ME, et al. Robotically driven interventions: a method of using CT fluoroscopy without radiation exposure to the physician. Radiology. 2002;225:277-282.
53. Wink MH, Lagerveld BW, Laguna MP, et al. Cryotherapy for renal-cell cancer: diagnosis, treatment, and contrast-enhanced ultrasonography for follow-up. J Endourol. 2006;20:456-459.
54. Clarke DM, Hollister WR, Baust JG, et al. Cryosurgical modeling: sequence of freezing and cytotoxic agent application affects cell death. Mol Urol. 1999;3:25-31.
55. Clarke DM, Baust JM, Van Buskirk RG, et al. Chemo-cryo combination therapy: an adjunctive model for the treatment of prostate cancer. Cryobiology. 2001;42:274-285.